Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Semin Oncol Nurs ; 9(3 Suppl 1): 20-4, 1993 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8210790

RESUMO

Clinical trials have demonstrated that rIL-2 can be safely administered in an outpatient setting. A thorough nursing assessment ensures patient safety and effective toxicity management. Because it is becoming more economically advantageous to treat patients on an outpatient basis, nurses will need to become involved in all aspects of managed care. Outpatient administration of rIL-2 challenges nurses to be both technologically expert and clinically proficient.


Assuntos
Interleucina-2/uso terapêutico , Neoplasias/enfermagem , Neoplasias/terapia , Pacientes Ambulatoriais , Serviços de Assistência Domiciliar , Humanos , Interleucina-2/efeitos adversos , Programas de Assistência Gerenciada , Avaliação em Enfermagem , Proteínas Recombinantes/uso terapêutico , Autocuidado
2.
Am J Surg ; 152(1): 100-4, 1986 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-3728801

RESUMO

Palliative terminal care of patients with malignant bowel obstruction is a major clinical and ethical challenge. These patients are often mentally alert and ambulatory, but are kept in the hospital for hydration, nasogastric suction, and pain control. Parenteral nutrition requires frequent metabolic monitoring, is expensive, and is ethically questionable. We have used an alternative method of home management for 27 patients who met the following criteria: inoperable bowel obstruction due to untreatable cancer, an estimated life expectancy of between 2 weeks and 3 months, and understanding of the goals and limits of therapy. Hydration was provided by 10 percent dextrose and electrolyte solutions administered as overnight infusions through long-term central venous catheters. Thirteen patients with complete bowel obstruction required a venting gastrostomy which, when connected to passive drainage, relieved nausea and vomiting. The mean duration of survival was 64 days (range 9 to 223 days). Acceptance by patients and families was excellent, although most acknowledged increased costs due to limited insurance coverage for outpatient care. Seven patients returned to the hospital for terminal care (average stay 3.2 days), and 20 chose to die at home. The mean daily expense for fluids and supplies was +73.50, with an overall cost decrease of $900,000 compared with inpatient care. Home support with fluids and gastric venting is a humane, cost-effective alternative to in-hospital care for selected patients.


Assuntos
Neoplasias Abdominais/complicações , Hidratação , Gastrostomia , Serviços de Assistência Domiciliar , Obstrução Intestinal/terapia , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Custos e Análise de Custo , Feminino , Serviços de Assistência Domiciliar/economia , Humanos , Obstrução Intestinal/etiologia , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA